Cargando…

DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma

Hepatocellular Carcinoma (HCC) is one of the most fatal cancers, whose incidence and death rates are still rising. Here, we report the identification of long non-coding RNAs (IncRNAs) that associated with HCC progression and metabolism based on the systematically analysis of large scale RNA-seq data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Min, Zhang, Xiao-Yu, Yu, Heguo, Xiang, Shi-Hao, Xu, Ling, Wei, Jue, Wu, Qiong, Jia, Rongrong, Wang, Yu-Gang, Lu, Xiao-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546473/ https://www.ncbi.nlm.nih.gov/pubmed/28496001 http://dx.doi.org/10.18632/oncotarget.17409

Ejemplares similares

HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
por: Dong, Mei-Ling, et al.
Publicado: (2022)

The Role of Upregulated DDX11 as A Potential Prognostic and Diagnostic Biomarker in Lung Adenocarcinoma
por: Li, Jianhao, et al.
Publicado: (2019)

The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Luo, Xiaojun, et al.
Publicado: (2022)

Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53- and caspase-3-mediated mechanisms
por: Shi, Min, et al.
Publicado: (2016)

Hsa_circ_0007456 regulates the natural killer cell-mediated cytotoxicity toward hepatocellular carcinoma via the miR-6852-3p/ICAM-1 axis
por: Shi, Min, et al.
Publicado: (2021)

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

An E2F1/DDX11/EZH2 Positive Feedback Loop Promotes Cell Proliferation in Hepatocellular Carcinoma
por: Su, Shu-Guang, et al.
Publicado: (2021)

DDX3, a potential target for cancer treatment
por: Bol, Guus Martinus, et al.
Publicado: (2015)

DDX10 and BYSL as the potential targets of chondrosarcoma and glioma
por: Quan, Xuemin, et al.
Publicado: (2021)

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
por: Liao, Hao, et al.
Publicado: (2021)

Silenced lncRNA DDX11-AS1 or up-regulated microRNA-34a-3p inhibits malignant phenotypes of hepatocellular carcinoma cells via suppression of TRAF5
por: Ding, Gangqiang, et al.
Publicado: (2021)

DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
por: Yuan, Mengping, et al.
Publicado: (2022)

DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity
por: Xue, Ying, et al.
Publicado: (2019)

E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway
por: Yu, Yan, et al.
Publicado: (2020)

Correction to: Silenced lncRNA DDX11-AS1 or up-regulated microRNA-34a-3p inhibits malignant phenotypes of hepatocellular carcinoma cells via suppression of TRAF5
por: Ding, Gangqiang, et al.
Publicado: (2021)

DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma
por: Li, Hao-Kang, et al.
Publicado: (2016)

miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F
por: Luo, Gang, et al.
Publicado: (2015)

Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expression
por: XU, LING, et al.
Publicado: (2015)

Morphine may act via DDX49 to inhibit hepatocellular carcinoma cell growth
por: Dai, Huijun, et al.
Publicado: (2021)

DDX55 promotes hepatocellular carcinoma progression by interacting with BRD4 and participating in exosome‐mediated cell‐cell communication
por: Yu, Bin, et al.
Publicado: (2022)

DDX20: A Multifunctional Complex Protein
por: He, Lu, et al.
Publicado: (2023)

DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA18
por: Gan, Hairun, et al.
Publicado: (2022)

Coexistence of primary clear cell subtype of hepatocellular carcinoma, cholangiocarcinoma, and ordinary type hepatocellular carcinoma: A case report
por: Xu, Jian, et al.
Publicado: (2023)

TMEM206 is a potential prognostic marker of hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

2B and 3C Proteins of Senecavirus A Antagonize the Antiviral Activity of DDX21 via the Caspase-Dependent Degradation of DDX21
por: Zhao, Kuan, et al.
Publicado: (2022)

Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway
por: Shi, Min, et al.
Publicado: (2019)

Predicting miRNA targets for hepatocellular carcinoma with an integrated method
por: Shi, Yi-Hua, et al.
Publicado: (2020)

E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma
por: Lv, Yi, et al.
Publicado: (2017)

Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma
por: Yan, Jia, et al.
Publicado: (2023)

Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma
por: Han, Ke‐qi, et al.
Publicado: (2016)

Perturbation Analysis of a Prognostic DDX3X-Mediated Gene Expression Signature Identifies the Antimetastatic Potential of Chaetocin in Hepatocellular Carcinoma
por: Lin, Tsung-Chieh
Publicado: (2023)

Role of the DDX11 DNA Helicase in Warsaw Breakage Syndrome Etiology
por: Santos, Diana, et al.
Publicado: (2021)

Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly
por: Yang, Fenghua, et al.
Publicado: (2023)

DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway
por: Zhang, Tong, et al.
Publicado: (2018)

The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome
por: Zheng, Bo‐Hao, et al.
Publicado: (2020)

RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin–ferroptosis axis
por: Li, Zhili, et al.
Publicado: (2023)

Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
por: Zhang, Ting, et al.
Publicado: (2021)

Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinoma
por: JIANG, JIA-HAO, et al.
Publicado: (2014)

Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis
por: Ouyang, Xiao, et al.
Publicado: (2020)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g4dj0n737nhbaii7pc4bv6giu4